Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HERO: Roflumilast in COPD Hyperinflation
NCT00108823Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of roflumilast in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Oct 2004; status: completed.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00108823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108823.